RxDoctor Payments Data

Mark Weems

Neonatal-Perinatal Medicine · Memphis, TNNPI 1477793362

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $101,544 of the $142,110 with a category attached, or 71.5%. Abbott accounts for 99.9% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2022 at $55,826 and has fallen 98.0% since, to $1,111 in 2025. Among neonatal-perinatal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,110in general payments, 2019–2025

Across 294 payments — averaging $483.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$142K
  • Penumbra, Inc.$138

What the payments were for

  • Consulting fees$11,1388%
  • Speaking & faculty fees$101,54471%
  • Travel & lodging$22,85416%
  • Food & beverage$6,5755%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott293$141,973
Penumbra, Inc.1$138

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,110 in reported general payments places this provider in the 95th percentile of 81 neonatal-perinatal medicine providers in Tennessee.

See all neonatal-perinatal medicine providers in Tennessee

Other neonatal-perinatal medicine in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →